[Federal Register Volume 61, Number 204 (Monday, October 21, 1996)]
[Notices]
[Page 54686]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-26888]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a meeting 
of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on 
November 14-15, 1996. The meeting will take place at the address 
provided below. All sessions of the meeting will be open to the public, 
except where specifically noted otherwise.
    Topics of discussion will include: (1) Discussion of Strategic 
Assessment and Direction Setting Issues Papers, (2) Status reports on 
(a) the Advance Notice for Proposed Rulemaking for Part 33, ``Specific 
Domestic Licensees of Broad Scope for Byproduct Material,'' (b) Modules 
for Regulatory Guide 10.8, ``Guide for the Preparation of Applications 
for Medical Use Programs,'' (c) Memorandum of Understanding with the 
U.S. Food and Drug Administration, and (d) Continuing Implementation of 
the Quality Management Rule; (3) discussion of regulatory authorization 
for intravascular brachytherapy, including the petition of IsoStent 
intravascular brachytherapy and the development of criteria and 
training and experience requirements; (4) discussion of security and 
control of byproduct materials in medical and university settings; (5) 
discussion of mobile high-dose-rate afterloader applications; and (6) 
discussion of inspection guidance for the final rule on patient 
release. The staff will also provide an update on several rulemakings 
and regulatory guides: (1) Petition by Tri-Med for carbon-14 use; (2) 
Release of Patients (10 CFR 35.75); (3) ``Reporting Requirements for 
Unauthorized Use of Licensed Radioactive Material;'' and (4) Regulatory 
Guide for the final rule, ``Preparation, Transfer for Commercial 
Distribution, and Use of Byproduct Material for Medical Use.'' In 
addition, on November 14, 1996, 8:00 a.m.--9:00 a.m., there will be a 
closed session of the ACMUI to discuss ethics rules and their 
application. This session will be closed to prevent invasion of 
personal privacy of committee members.

DATES: The meeting will begin at 9 a.m., on November 14, 1996, and 8:00 
a.m. on November 15, 1996.

ADDRESSES: U.S. Nuclear Regulatory Commission, Two White Flint North, 
11545 Rockville Pike, Room T2B3, Rockville, MD 20852-2738.

FOR FURTHER INFORMATION, CONTACT: Torre Taylor, U.S. Nuclear Regulatory 
Commission, Office of Nuclear Material Safety and Safeguards, MS T8F5, 
Washington, DC 20555, Telephone (301) 415-7900.

Conduct of the Meeting

    Judith Ann Stitt, M.D., will chair the meeting. Dr. Stitt will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:

1. Persons who wish to provide a written statement should submit a 
reproducible copy to Torre Taylor (address listed previously), by 
November 8, 1996. Statements must pertain to the topics on the agenda 
for the meeting.
2. At the meeting, questions from members of the public will be 
permitted at the discretion of the Chairman.
3. The transcript and written comments will be available for 
inspection, and copying, for a fee, at the NRC Public Document Room, 
2120 L Street, N.W., Lower Level, Washington, DC 20555, telephone (202) 
634-3273, on or about November 22, 1996. Minutes of the meeting will be 
available on or about December 20, 1996.
4. Seating for the public will be on a first-come, first-served basis.

    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10, U.S. Code of Federal Regulations, Part 7.

    Dated: October 15, 1996.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 96-26888 Filed 10-18-96; 8:45 am]
BILLING CODE 7590-01-P